1.
S. Arebee A. CRISPR Gene-Editing Therapies for Sickle Cell Disease and Beta- Thalassemia: Clinical Outcomes, Risks and Safety Profiles. A Systematic Review. ljmas. 2025;3(4):102-108. doi:10.64943/ljmas.v3i4.254